Upper Extremity Deep Vein Thrombosis (DVT)

What is Upper Extremity DVT?

Upper extremity deep vein thrombosis (UEDVT) is the formation of a blood clot (thrombus) in the deep veins of the arm, shoulder, or chest wall. While most people associate DVT with the legs, clots can also develop in the veins that drain the arms, including the subclavian, axillary, brachial, and internal jugular veins. The clot can partially or completely block blood flow, causing pain, swelling, and, in some cases, life‑threatening complications such as pulmonary embolism (PE).

UEDVT accounts for roughly 4–10 % of all DVT cases, but its incidence is rising because of increased use of central venous catheters, implanted devices, and sedentary occupations that involve prolonged arm elevation.^[1][2]

Common Causes

UEDVT can be **primary** (spontaneous) or **secondary** (related to an identifiable trigger). The most frequent causes are:

• Central venous catheters (CVCs) or peripherally inserted central catheters (PICCs): The catheter irritates the vein wall, promoting clot formation.
• Implanted pacemakers and defibrillators: Leads travel through the subclavian or axillary veins and can cause endothelial injury.
• Thoracic outlet syndrome (TOS): Compression of the subclavian vein between the first rib and clavicle, often seen in athletes or people who perform repetitive overhead motions.
• Recent surgery or trauma to the shoulder, neck, or chest: Post‑operative immobility and tissue injury increase clot risk.
• Prolonged immobility or “tight” positioning: Long flights, car rides, or computer work with arms elevated for hours.
• Cancer and its treatments: Malignancy, especially of the lung, breast, or hematologic system, creates a hypercoagulable state.
• Inherited or acquired clotting disorders: Factor V Leiden, prothrombin gene mutation, antiphospholipid syndrome, etc.
• Hormonal influences: Oral contraceptives, hormone replacement therapy, and pregnancy increase clot risk.
• Inflammatory conditions: Rheumatoid arthritis or systemic lupus erythematosus can damage veins.
• Obesity and sedentary lifestyle: Contribute to overall venous stasis.

Understanding the underlying cause is essential because it guides both treatment and prevention strategies.^[3]

Associated Symptoms

Symptoms vary from mild to severe, depending on clot size and location. Commonly reported signs include:

• Swelling of the arm, hand, or forearm (often unilateral)
• Pain or a sense of heaviness that worsens with arm use
• Visible distention of superficial veins (collateral veins)
• Redness or a bluish‑purple discoloration of the skin
• Feeling of tightness or “fullness” in the chest if the subclavian or internal jugular vein is involved
• Reduced range of motion or weakness due to pain
• Fever or chills in rare cases (suggesting infection of a catheter)

Because these symptoms overlap with musculoskeletal injuries, UEDVT is sometimes missed without a high index of suspicion.^[4]

When to See a Doctor

Prompt medical evaluation is crucial to avoid complications. Seek care if you notice:

• Sudden or progressive swelling of one arm that does not improve with rest
• Persistent, throbbing pain that worsens when the arm is elevated
• Visible, rope‑like veins on the chest or upper arm
• Redness, warmth, or a feeling of heat over the affected area
• Shortness of breath, chest pain, or coughing up blood (possible pulmonary embolism)
• Fever, chills, or drainage from a catheter site

Even if symptoms seem mild, people with recent central lines, cancer, or known clotting disorders should contact their clinician promptly.^[5]

Diagnosis

Diagnosing UEDVT involves a combination of clinical assessment, imaging, and laboratory tests.

Clinical Prediction Scores

Tools such as the **Modified Wells Score** for upper extremity DVT help estimate pre‑test probability, guiding the need for further testing.

Imaging Studies

• Duplex ultrasonography: First‑line, non‑invasive test that evaluates blood flow and can directly visualize a thrombus.
• Contrast venography: Gold standard but used rarely due to invasiveness; reserved for equivocal ultrasound results.
• CT venography or MR venography: Helpful when central veins (subclavian, brachiocephalic) are involved or when ultrasound windows are limited.

Laboratory Tests

• D‑dimer: High sensitivity but low specificity; a normal result can help rule out DVT in low‑risk patients.
• Complete blood count, coagulation profile, and renal/liver function (baseline before anticoagulation).
• Thrombophilia work‑up (e.g., factor V Leiden, antiphospholipid antibodies) if the clot is unprovoked or in a young patient.

Treatment Options

Management aims to prevent clot propagation, reduce symptoms, and avoid serious complications such as PE or post‑thrombotic syndrome.

Anticoagulation

• Low‑molecular‑weight heparin (LMWH) (e.g., enoxaparin) or **unfractionated heparin** for initial therapy.
• Direct oral anticoagulants (DOACs) – apixaban, rivaroxaban, or dabigatran are increasingly favored for their ease of use and comparable efficacy to warfarin.^[6]
• Therapy duration: 3 months for provoked UEDVT (e.g., catheter‑related); 6 months or longer for unprovoked or recurrent events, often individualized.

Catheter‑Related Management

• If a central line is the culprit, clinicians may **remove, replace, or reposition** the catheter after initiating anticoagulation.
• In some cases, **catheter-directed thrombolysis** (CDT) or mechanical thrombectomy is considered for extensive clots causing severe symptoms.

Compression & Physical Measures

• Graduated compression sleeves (15–20 mmHg) can help reduce swelling once acute inflammation subsides.
• Gentle range‑of‑motion exercises improve venous return; however, vigorous exertion should be avoided until the clot stabilizes.

Pain Management

Acetaminophen or non‑steroidal anti‑inflammatory drugs (NSAIDs) can be used for discomfort, provided there are no contraindications (e.g., active bleeding risk).

Follow‑up Imaging

Repeat duplex ultrasound is usually performed 1–2 weeks after starting therapy to confirm clot resolution or stability.

Prevention Tips

While not all UEDVTs are preventable, several strategies can lower risk, especially in high‑risk populations.

• Maintain catheter hygiene: Follow aseptic technique, change dressings as recommended, and remove catheters as soon as they are no longer needed.
• Limit prolonged arm immobility: Take short breaks every 1–2 hours during long flights, drives, or desk work to gently move the arms.
• Exercise regularly: Activities that involve shoulder flexion and extension (e.g., swimming, light resistance bands) promote venous flow.
• Stay hydrated: Adequate fluid intake reduces blood viscosity.
• Weight management: Achieving a healthy BMI reduces overall thrombosis risk.
• Review medications: Discuss with your physician the risk‑benefit of hormonal therapies if you have additional clot risk factors.
• Screen for clotting disorders: If you have a personal or family history of unexplained clots, ask for a thrombophilia panel.
• Post‑surgical prophylaxis: Use prescribed compression sleeves or intermittent pneumatic compression devices after upper‑body surgery.

Emergency Warning Signs

---

References:

1. Mayo Clinic. “Upper extremity deep vein thrombosis (UEDVT).” Accessed May 2026.
2. American College of Chest Physicians. “Antithrombotic Therapy for VTE Disease.” CHEST 2021.
3. Cleveland Clinic. “Causes of Upper Extremity DVT.” 2023.
4. JAMA. “Clinical presentation of upper extremity deep vein thrombosis: a systematic review.” 2022.
5. National Institutes of Health (NIH). “Deep Vein Thrombosis – Signs and Symptoms.” 2024.
6. American Heart Association. “Direct Oral Anticoagulants for Upper Extremity DVT.” 2023.